## Abstract ## Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) is challenging due to the increased risk of iatrogenic movement disorders with old neuroleptics and the seemingly increasing risk of cardiovascular events wit
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: Preliminary findings from a naturalistic, retrospective study
✍ Scribed by PAOLA ROCCA; FEDERICA MARINO; CRISTIANA MONTEMAGNI; DAVIDE PERRONE; FILIPPO BOGETTO
- Book ID
- 108962197
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 70 KB
- Volume
- 61
- Category
- Article
- ISSN
- 1323-1316
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives Psychotic symptoms and behavioral disturbances are a concern in the care of elderly patients with Alzheimer's dementia (AD). This study was conducted to compare the efficacy of olanzapine versus placebo in patients with psychotic symptoms associated with AD in long‐term o
## Objective The objective of this study was to assess the safety and tolerability of extended‐release quetiapine fumarate (quetiapine XR) compared with quetiapine immediate‐release (quetiapine IR) in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation. ## Methods